The up-regulation of type I plasminogen activator inhibitor in human gingival fibroblasts stimulated with cyclosporin A

Journal of Periodontal Research

Volumn 42, Issue 1, 2007, Pages 39-44

  Lin, H J ^a   Tsai, C H ^a   Huang, F M ^a   Chang, Y C ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cyclosporin A; Gingival fibroblasts; Gingival overgrowth; Type I plasminogen activator inhibitor

Indexed keywords

COLORING AGENT; CYCLOSPORIN; DIAGNOSTIC AGENT; IMMUNOSUPPRESSIVE AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; CYTOPLASM; DRUG EFFECT; ENDOTHELIUM CELL; FIBROBLAST; GINGIVA; GINGIVA OVERGROWTH; HUMAN; INFLAMMATION; METABOLISM; TIME; UPREGULATION;

CELLS, CULTURED; COLORING AGENTS; CYCLOSPORINE; CYTOPLASM; ENDOTHELIAL CELLS; FIBROBLASTS; GINGIVA; GINGIVAL OVERGROWTH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; TIME FACTORS; UP-REGULATION;

EID: 33846027811     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2006.00912.x     Document Type: Article

References (30)

1. Faulds D, Goa KL, Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993;45:953-1040.
2. Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van Buren CT. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 1987;43:197-204.
3. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: a side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
4. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
5. Tyldesley WR, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984;157:305-309.
6. Rostock MH, Fry HR, Turner JE. Severe gingival overgrowth associated with cyclosporine therapy. J Periodontol 1986;57:294-299.
7. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987;69:381-387.
8. Collen D. Natural inhibitors of fibrinolysis. J Clin Pathol 1980;14:24-30.
9. Barazzone C, Belin D, Piguet PF, Vassalli JD, Sappino AP. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest 1996;98:2666-2673.
10. Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells. J Hepatol 1999;31:703-711.
11. Takeshita K, Hayashi M, Iino S et al. Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction. Am J Pathol 2004;164:449- 456.
12. Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 2003;39:367-372.
13. Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 1996;97:232-237.
14. Buduneli N, Buduneli E, Ciotanar S, Atilla G, Lappin D, Kinane D. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients. J Clin Periodontol 2004;31:556-561.
15. Chang YC, Tsai CH, Yang SH, Liu CM, Chou MY. Induction of cyclooxygenase-2 mRNA and protein expression in human gingival fibroblasts stimulated with nicotine. J Periodont Res 2003;38:496-501.
16. Chang YC, Lai CC, Lin LF, Ni WF, Tsai CH. The upregulation of heme oxygenase-1 expression in human gingival fibroblasts stimulated with nicotine. J Periodont Res 2005;40:252-257.
17. Chang YC, Hsieh YS, Lii CK, Huang FM, Tai KW, Chou MY. Induction of c-fos expression by nicotine in human periodontal ligament fibroblasts is related to cellular thiol levels. J Periodont Res 2003;38:44-50.
18. Vassalii JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991;88:1067-1072.
19. Shihab FS, Andoh TF, Tanner AM, Nobel NA, Border WA, Franceschini N, Bennett WM. Role of transforming growth factor-beta 1 in experimental chronic cyclosporin nephropathy. Kiney Int 1996;49:1141-1151.
20. Shihab FS, Yi H, Bennett WM, Andoh TF. Effect of nitric oxide modulation on TGF-beta 1 and matrix protein in chronic cyclosporin nephrotoxicity. Kidney Int 2000;58:1174-1185.
21. Verpooten GA, Cools FJ, Van Gaal LF, DeBroe ME. Elevated plasminogen activator inhibitor levels in cyclosporine-treated renal allograft recipients. Nephrol Dial Transplant 1996;11:347-351.
22. Sugano N, Ito K, Murai S. Cyclosporin A inhibits collagenases gene expression via AP-1 and JNK suppression in human gingival fibroblasts. J Periodont Res 1998;33:448-452.
23. Bolzani G, Coletta RD, Matelli JH, Almeida OP, Graner E. Cyclosporin A inhibits production and activity of matrix metalloproteinases by gingival fibroblasts. J Periodont Res 2000;35:51-58.
24. Hyland PL, Traynor PS, Myrillas TT et al. The effects of cyclosporine on the collagenolytic activity of gingival fibroblasts. J Periodontol 2003;74:437-445.
25. Birkedal-Hansen H, More WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, Decrol A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
26. Baricos WH, Cortez SL, EL-Dahr SS, Schnaper HW. extracellular matrix degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 1996;47:1039-1047.
27. Cortrim P, de Andrade CR, Martelli-Junior H, Graner E, Sauk JJ, Coletta RD. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-β1 autocrine stimulation. J Periodontol 2002;73:1313-1322.
28. Bostrom A, Bharath H, Saulewicz A, Narayanan AS. Cyclosporin A affects signal events differentially in human gingival fibroblasts. J Dent Res 2005;84:532-536.
29. Mucsi I, Skorecki KL, Goldberg HJ. Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-beta 1 on gene expression. J Biol Chem 1996;271:16567-16572.
30. Chen HC, Feener EP. MEK1,2 response element mediates angiotensin II-stimulated plasminogen activator inhibitor-1 promoter activation. Blood 2004;103:2636-2644.